MedTrace Logo

Diabetes and Cognitive Functions in Middle Age

NCT05919927 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2023-06-27

No results posted yet for this study

Summary

This study will examine the effects of type II diabetes on cognitive functions and mood in middle-aged patients. In addition, the association between cognitive functions and glycemic controls is studied in patients. Sixty patients and sixty healthy controls will be recruited and assessed by a multiprofessional team (neuropsychologist, physician).

Conditions

Sponsors & Collaborators

  • Tampere University

    collaborator OTHER

  • Tampere University Hospital

    lead OTHER

Principal Investigators

  • Mervi Jehkonen, PhD · Tampere University

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-07
Primary Completion
2022-12-31
Completion
2024-12-30

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05919927 on ClinicalTrials.gov